Partner Overview

Our core business is in clinical innovation to meet unmet needs. Cingulate Therapeutics’ partnership philosophy focuses on entities that can help accelerate development of our current assets or support the company’s valuation. We will also consider partnerships related to future products and in-licensing opportunities for central nervous systems and other neurobiological disorders as well as new indications for current assets.


We are always open to exploring collaborations with other companies that have similar philosophies and are motivated to improve lives and create significant value. We invite you to learn more about Cingulate and share your business opportunity by sending an email to Business Development by using our ONLINE FORM

Key Partners

Bio-images Drug Delivery Ltd (BDD) is a privately-owned drug delivery company specializing in the development of modified and controlled release oral formulations. BDD’s OralogiK™ technology is a tablet-in-tablet drug delivery system providing timed release, sustained release and the opportunity for complex bi- and tri-phasic release of one or multiple drugs. The OralogiK™ technology is protected with granted patents in the US, EU and Japan. BDD has in house clinical trial capabilities for conduct of gamma scintigraphic/ pharmacokinetic studies in men.

Camargo Pharmaceutical Services is the most experienced team of experts providing comprehensive drug development services specialized for the 505(b)(2) approval pathway and global equivalent processes. By assessing the scientific, medical, regulatory, and commercial viability of product development opportunities, Camargo systematically builds and executes robust development plans that align with business strategies and ensure Agency buy-in every step of the way.

Lowenstein Sandler is a national law firm with approximately 300 lawyers based in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. The firm represents leaders in virtually every sector of the global economy, with particular emphasis on investment funds, life sciences, and technology.

A Boston institution since 1933, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo is now a national powerhouse, claiming such blue chippers as Biogen Idec and General Electric as clients. Bay State pedigree notwithstanding, Mintz Levin’s gaze has shifted westward-namely to the IP-rich tech and biotech hubs of San Diego and Silicon Valley, and recently to San Francisco.

ProPharma Group, Inc. provides compliance, validation, and technical services to pharmaceutical, medical device, biotechnology, and dietary supplement industries.

Tiberend Strategic Advisors, Inc. is a full-service investor and corporate communications firm specializing in the healthcare and life sciences industry.